ELV - Senseonics announces a positive coverage decision for Eversense E3 CGM from Anthem
- Senseonics Holdings ( NYSE: SENS ) on Wednesday said Anthem, now called Elevance Health ( ELV ), is providing coverage for implantable continuous glucose monitoring (CGM) systems for diabetic people, which includes the company's Eversense CGM System.
- SENS stock had gained 7.1% to $1.36 in premarket trading.
- SENS said Anthem's coverage decision adds over 45M covered lives for the Eversense E3 CGM System.
- The decision allows SENS' global commercial partner, Ascensia Diabetes Care, to introduce the Eversense CGM System to more people living with diabetes.
For further details see:
Senseonics announces a positive coverage decision for Eversense E3 CGM from Anthem